MedDataX Logo

Trial Outcomes & Findings for Testing the Re-Engineered Hospital Discharge (NCT NCT00252057)

NCT ID: NCT00252057

Last Updated: 2017-03-28

Results Overview

The total number of rehospitalizations (emergency department visits plus hospital admissions) in the 30 days after discharge, compared across study arms. Participants could have more than one rehospitalization in this period; all rehospitalizations for each were counted, making the unit of measure the rehospitalizations and not the participants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

749 participants

Primary outcome timeframe

30 days after discharge

Results posted on

2017-03-28

Participant Flow

All participants were recruited between January 1, 2006 and October 16, 2007, from the general medical floors at Boston Medical Center.

The baseline interview was conducted after enrollment and prior to group assignment, but it did not affect this assignment or lead to exclusion from the study for any participant. All participants who gave consent and agreed to be in the study were assigned to a group

Participant milestones

Participant milestones
Measure
Re-engineered Hospital Discharge
Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge
Participants received the routine, standard hospital discharge.
Overall Study
STARTED
373
376
Overall Study
COMPLETED
370
368
Overall Study
NOT COMPLETED
3
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Re-engineered Hospital Discharge
Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge
Participants received the routine, standard hospital discharge.
Overall Study
Withdrawal by Subject
2
5
Overall Study
Death
1
2
Overall Study
Participant previously enrolled
0
1

Baseline Characteristics

Testing the Re-Engineered Hospital Discharge

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Re-engineered Hospital Discharge
n=373 Participants
Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge
n=376 Participants
Participants received the routine, standard hospital discharge.
Total
n=749 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
312 Participants
n=93 Participants
314 Participants
n=4 Participants
626 Participants
n=27 Participants
Age, Categorical
>=65 years
61 Participants
n=93 Participants
62 Participants
n=4 Participants
123 Participants
n=27 Participants
Age, Continuous
50.1 years
STANDARD_DEVIATION 15.1 • n=93 Participants
49.6 years
STANDARD_DEVIATION 15.3 • n=4 Participants
49.9 years
STANDARD_DEVIATION 15.2 • n=27 Participants
Sex: Female, Male
Female
178 Participants
n=93 Participants
199 Participants
n=4 Participants
377 Participants
n=27 Participants
Sex: Female, Male
Male
195 Participants
n=93 Participants
177 Participants
n=4 Participants
372 Participants
n=27 Participants
Region of Enrollment
United States
373 participants
n=93 Participants
376 participants
n=4 Participants
749 participants
n=27 Participants

PRIMARY outcome

Timeframe: 30 days after discharge

The total number of rehospitalizations (emergency department visits plus hospital admissions) in the 30 days after discharge, compared across study arms. Participants could have more than one rehospitalization in this period; all rehospitalizations for each were counted, making the unit of measure the rehospitalizations and not the participants.

Outcome measures

Outcome measures
Measure
Re-engineered Hospital Discharge
n=370 Participants
Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge
n=368 Participants
Participants received the routine, standard hospital discharge.
Total Number of Rehospitalizations (Emergency Department Visits Plus Hospital Admissions) in the 30 Days After Discharge.
116 Total number of rehospitalizations
166 Total number of rehospitalizations

Adverse Events

Re-engineered Hospital Discharge

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Hospital Discharge

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Brian Jack PI

Boston Medical Center

Phone: 617-414-44675

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place